Prenetics Global Ltd (PRE)

Currency in USD
21.1350
-0.1350(-0.63%)
Real-time Data·
PRE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
20.820021.3104
52 wk Range
11.365027.2400
Key Statistics
Prev. Close
21.27
Open
21.3104
Day's Range
20.82-21.3104
52 wk Range
11.365-27.24
Volume
20.41K
Average Volume (3m)
239.01K
1-Year Change
51.0722%
Book Value / Share
5.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
38.1250
Upside
+80.39%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Prenetics Global Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 38.1250
(+80.39% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Lucid Capital Markets
Buy54.00+156.05%-New Coverage12/10/2026
Craig-Hallum
Buy40.00+89.66%-New Coverage17/09/2026
StoneX
Buy40.00+89.66%40.00Maintain08/09/2026
B.Riley
Buy37.00+75.44%-New Coverage27/08/2026
Benchmark
Buy40.00+89.66%30.00Maintain15/07/2026

Prenetics Global Ltd Earnings Call Summary for Q2/2026

  • Prenetics Q2 EPS of -$0.53 beat estimates by 25%, but revenue of $46.5M missed forecasts by 5.4%, sending shares down 1.91% to $19.
  • Gross margin improved to 65% from 62% YoY; July marked first-ever positive adjusted free cash flow at $20.9M revenue, implying $251M annual run rate.
  • Company raised FY guidance to $220M-$230M revenue; Q3 expected at $63M-$64M with H2 adjusted EBITDA loss improving to -$8M to -$12M range.
  • IM8 wellness segment drove growth with $45M revenue, up 33% sequentially; new products IM8 Hydration (Q4) and Premium Gummies (Q1 2025) not in guidance.
  • Management emphasized marketing efficiency gains and science-based positioning, maintaining 95% direct-to-consumer focus with no near-term retail expansion plans.
Last Updated: 19/08/2026, 12:18 am
Read Full Transcript

Earnings

Latest Release
18/08/2026
EPS / Forecast
-0.53 / -0.71
Revenue / Forecast
46.5M / 49.15M
EPS Revisions
Last 90 days

PRE Income Statement

Compare PRE to Peers and Sector

Metrics to compare
PRE
Peers
Sector
Relationship
P/E Ratio
−6.4x−15.8x−0.3x
PEG Ratio
−0.270.010.00
Price/Book
3.9x3.5x2.6x
Price / LTM Sales
2.3x1.5x2.9x
Upside (Analyst Target)
80.1%29.6%63.9%
Fair Value Upside
Unlock−5.4%9.4%Unlock

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
21.54K0.13%455.79K
Other Institutional Investors
1.22M7.18%25.74M
Public Companies & Retail Investors
15.70M92.69%332.21M
Total
16.94M100.00%358.4M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Prospect Capital Advisors, LLC1.39%235,8004,990
Jane Street Group, LLC1.33%225,0934,763

People Also Watch

206.8000
NUTX
+1.19%
12.11
BLZE
-3.20%
83.42
MXL
-5.89%

FAQ

What Is the Prenetics Global (PRE) Stock Price Today?

The Prenetics Global stock price today is 21.1350 USD.

What Stock Exchange Does Prenetics Global Trade On?

Prenetics Global is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Prenetics Global?

The stock symbol for Prenetics Global is "PRE."

What Is the Prenetics Global Market Cap?

As of today, Prenetics Global market cap is 360.2700M USD.

What Is Prenetics Global's Earnings Per Share (TTM)?

The Prenetics Global EPS (TTM) is -3.4876.

When Is the Next Prenetics Global Earnings Date?

Prenetics Global will release its next earnings report on 05/11/2026.

From a Technical Analysis Perspective, Is PRE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Prenetics Global Stock Split?

Prenetics Global has split 2 times.

How Many Employees Does Prenetics Global Have?

Prenetics Global has 98 employees.

What is the current trading status of Prenetics Global (PRE)?

As of 14/10/2026, Prenetics Global (PRE) is trading at a price of 21.1350 USD, with a previous close of 21.2700 USD. The stock has fluctuated within a day range of 20.8200 USD to 21.3104 USD, while its 52-week range spans from 11.3650 USD to 27.2400 USD.

What Is Prenetics Global (PRE) Price Target According to Analysts?

The average 12-month price target for Prenetics Global is 38.1250 USD, with a high estimate of 54 USD and a low estimate of 30 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +80.39% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.